Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10373314" target="_blank" >RIV/00216208:11110/17:10373314 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20170823&DB=&locale=en_EP&CC=EP&NR=2927230B1&KC=B1&ND=1" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20170823&DB=&locale=en_EP&CC=EP&NR=2927230B1&KC=B1&ND=1</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pentamethinium salts with an expanded quinoxaline unit and its use in anticancer therapy
Original language description
The invention describes the use of systems based on pentamethinium salts with an expanded quinoxaline unit, the unit being incorporated into a pentamethinium chain. The systems can be used in anticancer therapy. The systems are based on the use of a structural motif of pentamethinium salts prepared from corresponding malondialdehyde with a quinaxoline unit. / RIV19: Patent is exploited by its owner, there is not any sold licence yet.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
<a href="/en/project/ED1.1.00%2F02.0109" target="_blank" >ED1.1.00/02.0109: Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP2927230
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Aug 23, 2017
Owner name
University of Chemistry and Technology; First Faculty of Medicine; Institute of Molecular Genetics of ASCR
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence